Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRegional Reit Regulatory News (RGL)

Share Price Information for Regional Reit (RGL)

Share Price is delayed by 15 minutes
Get Live Data
88.90    0.50 (0.57%)
Bid:
85.60
Ask:
88.80
Spread: 3.20 (3.738%)
Market Cap: £144.10m
RGL Live PriceLast checked at - London Stock Exchange

Intraday Regional Reit Share Chart

Banking Facility Refinanced

24 Dec 2025 07:00

RNS Number : 7074M
Regional REIT Limited
24 December 2025
 

24 December 2025

REGIONAL REIT Limited

("Regional REIT", the "Group" or the "Company")

£72.4m Banking Facility Refinanced to December 2028

 

Regional REIT Limited, the regional commercial property specialist, is pleased to announce that it has successfully agreed a 3-year extension to the debt facility (the "Facility"), which was due to mature in August 2026. This Facility was originally £128.0m. Through an active debt reduction programme of property disposals, the outstanding balance has been significantly reduced to £72.4m (31 December 2024: £99.8m).

The Facility's margin remains unchanged. In line with company policy, the Facility will be fully hedged to maturity. The existing hedging remains in place until August 2026, after which new hedging will commence beginning then through to expiry.

With the Facility extension, the lending group will comprise of The Royal Bank of Scotland, the Bank of Scotland and Santander UK plc. The Company has the ability to request two one-year extensions to the Facility's expiry date, pending lender approval.

As a result of the refinancing the Group's weighted average unexpired debt term will extend to 2.6 years. There will initially be no change to the cost of borrowing until the expiry of the existing hedge, at which point it is anticipated that the weighted average cost of debt will increase to circa 4.1% from 3.4%.

 

Stephen Inglis, Head of ESR Europe LSPIM, Investment Adviser commented:

"Securing this facility extension on competitive terms underlines the strength of our banking relationships and the attractiveness of our portfolio. The 3-year extension of the £72.4 facility will provide stability as we continue to execute our strategy, with a focus on continuing to reduce debt, improving income and adding value via our capex programme."

 

 

 

- ENDS -

ESR Europe Investment Management Ltd

Tel: +44 (0) 203 831 9776

Investor Relations

Adam Dickinson

 

ESR Europe LSPIM Limited

Tel: +44 (0) 141 248 4155

Investment Adviser to the Group

Stephen Inglis

FTI Consulting

Tel: +44 (0)20 3727 1000

Financial Communications

RegionalREIT@fticonsulting.com

Dido Laurimore, Giles Barrie

 

About Regional REIT

 

Regional REIT Limited ("Regional REIT" or the "Company") and its subsidiaries (the "Group") is a United Kingdom ("UK") based real estate investment trust that launched in November 2015. It is managed by ESR Europe LSPIM Limited, the Asset Manager, and ESR Europe Private Markets Limited, the Investment Adviser.

 

Regional REIT's commercial property portfolio is comprised wholly of income producing UK assets, predominantly offices located in the regional centres outside of the M25 motorway. The portfolio is geographically diversified, with 118 properties, 1,242 units and 690 tenants as at 30 September 2025, with a valuation of c.£595.9m.

Regional REIT pursues its investment objective by investing in, actively managing and disposing of regional Core and Core Plus Property assets. It aims to deliver an attractive total return to its Shareholders with a strong focus on income supported by additional capital growth prospects.

 

The Company's shares were admitted to the Official List of the UK's Financial Conduct Authority and to trading on the London Stock Exchange on 6 November 2015. For more information, please visit the Group's website at www.regionalreit.com.

 

LEI: 549300D8G4NKLRIKBX73

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCXXLFLELLXFBX
Date   Source Headline
19th Jul 20243:44 pmRNSNotice of AGM
18th Jul 20242:24 pmRNSResult of EGM
28th Jun 20243:21 pmRNSDirector/PDMR Shareholding
27th Jun 202411:00 amRNSPublication of Prospectus
27th Jun 20247:00 amRNSUnderwritten £110.5m Capital Raise & Notice of EGM
22nd May 20247:00 amRNSQ1 2024 Trading Update, Dividend and EPC Update
1st May 20247:00 amRNSPositive Letting Update
22nd Apr 20245:36 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSPositive Letting Update
26th Mar 20247:00 amRNS2023 Full Year Results
12th Mar 20247:00 amRNSResponse to Press Speculation
22nd Feb 20247:00 amRNSDividend Declaration
2nd Feb 20247:00 amRNSQ4 23 Valuation and Portfolio Update
9th Nov 20237:00 amRNSQ3 23 Trading Update, Dividend and ESG Update
9th Nov 20237:00 amRNSOffice Sale 26.3% above Valuation
31st Oct 20237:00 amRNSNorfolk House – Positive Letting Update
12th Oct 202312:29 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSAppointment of ARA Europe as Investment Adviser
3rd Oct 20237:15 amEQSRegional REIT: Dividend rebase pragmatic and sustainable
12th Sep 20237:00 amRNSQ2 2023 Dividend Declaration
12th Sep 20237:00 amRNS2023 Half Year Results
11th Aug 202311:34 amRNSReplacement - Released in Error
11th Aug 20237:00 amRNSEdison issues update on Target Healthcare REIT
9th Jun 20237:00 amRNSUpdate on Office Occupancy
25th May 20233:14 pmRNSResult of AGM
24th May 20237:00 amRNSTrading Update and Dividend Declaration
14th Apr 20234:00 pmRNSQuotedData's Weekly News & Interview
13th Apr 20237:00 amRNSAsset Manager Update
30th Mar 20239:30 amRNSAsset Manager Update
28th Mar 20237:00 amRNSFinal Results
23rd Feb 20237:00 amRNSQ4 22 Divi, Letting Update & FY22 Valuation
14th Feb 20237:00 amRNSPositive Update on Office Use
13th Dec 20227:00 amRNSPositive Lettings Update
11th Nov 202210:05 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSQ3 2022 Trading Update and Dividend Declaration
20th Oct 20224:13 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSDividend Declaration
15th Aug 20225:03 pmRNSDirector/PDMR Shareholding
15th Aug 20225:01 pmRNSDirector/PDMR Shareholding
15th Aug 20224:58 pmRNSDirector/PDMR Shareholding
15th Aug 202211:58 amRNSDirector/PDMR Shareholding
12th Aug 20224:45 pmRNSDirector/PDMR Shareholding
12th Aug 20224:44 pmRNSDirector/PDMR Shareholding
12th Aug 20224:42 pmRNSDirector/PDMR Shareholding
12th Aug 20224:41 pmRNSDirector/PDMR Shareholding
7th Jul 202212:01 pmRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding
4th Jul 20225:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.